Author:
Cao Yabing,Sun Yunjing,Miao Bo,Zhang Xiao,Zhao Qingzhou,Qi Liping,Chen Yaoqi,Zhu Lingling
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. He JC, WuY, Wang YD. The independent association between age and serum cholesterol levels in patients with familial hypercholesterolemia. Discov Med. 2022;34(173):171–80.
2. Slivnick J, Lampert BC. Hypertension and heart failure. Heart Fail Clin. 2019;15(4):531–41.
3. Di Palo KE, Barone NJ. Hypertension and heart failure: prevention, targets, and treatment. Cardiol Clin. 2022;40(2):237–44.
4. Jackson AM, Jhund PS, Anand IS, Düngen HD, Lam CSP, Lefkowitz MP, Linssen G, Lund LH, Maggioni AP, Pfeffer MA, Rouleau JL, Saraiva JFK, Senni M, Vardeny O, Wijkman MO, Yilmaz MB, Saito Y, Zile MR, Solomon SD, McMurray JJV. Sacubitril-Valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. Eur Heart J. 2021;42(36):3741–52.
5. Maron BA, Kovacs G, Vaidya A, Bhatt DL, Nishimura RA, Mak S, Guazzi M, Tedford RJ. Cardiopulmonary hemodynamics in pulmonary hypertension and heart failure: JACC review topic of the week. J Am Coll Cardiol. 2020;76(22):2671–81.